Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia

ONO-5046Na Phase II Study - A Pilot Study for Patients With Acute Respiratory Failure

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00417326

Enrollment

174

Registered

2007-01-01

Start date

2006-12-31

Completion date

Unknown

Last updated

2012-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired Pneumonia

Keywords

ONO-5046Na, acute respiratory failure, community-acquired pneumonia

Brief summary

The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia

Interventions

DRUGONO-5046Na

twenty four hour infusion at 0 mg/kg/hr for 14 days

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

20 Years to 79 Years

Healthy volunteers

Inclusion criteria

* Patients with community-acquired pneumonia * Patients with acute respiratory failure

Exclusion criteria

* Patients with nosocomial pneumonia * Patients on mechanical ventilation

Design outcomes

Primary

Measure	Time frame
pulmonary function	14 days

Secondary

Measure	Time frame
mortality	28 days
ventilator status	28 days

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026